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The genus Brucella is a worldwide distributed intracellular bacteria, which infects animals and 
human. Currently, this zoonosis has been diagnosed by microbiological and serological laboratory 
tests. Different PCR protocols with various primer pairs and different target genes have been 
published for the detection of Brucella, but only a few of these primers have been used in human 
samples. This study aimed to evaluate and compare the sensitivity and specificity of three primer pairs 
in the PCR technique, each of which separately amplifies three different regions in the Brucella 
genome, to determine which are more comfortable for the detecting of Brucella DNA in human 
clinical samples.  
49 clinical serum samples were isolated from suspected patients in different cities in Iran from 
October 2017 to July 2018. The suspected patients with	 brucellosis-compatible symptoms were 
checked.	These primers amplified 3 distinctive fragments in BCSP 31 gene (B4/B5), Designed IS711 
primers, and a sequence of 16SrRNA of Brucella melitensis.  
The results showed that the B4/B5 primer pair had the highest sensitivity and specificity for the 
detection of both positive and negative samples (100%). The designed IS711 primer pair detected 
94% of samples, whereas the 16SrRNA primer pair was the least sensitivity, being able to detect only 
30.64% of samples. 
The specificity of 3 techniques was 100%. The B4/B5 primers were able to detect the smallest number 
of bacteria 0.05 CFU/reaction whereas IS711 was able to detect 2 CFU/reaction and 16SrRNA was 
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Introduction 
Brucellosis is the second zoonotic disease after 
rabies (1).  Brucellosis has four phases that 
included: acute, subacute, and chronic and 
localize. Each phase has its own manifestation 
such as:	 joint pain, symptoms of poisoning, 
chronic spine, fever, sweating, testis or ovarian 
inflammation, neurological complications and 
arthritis in acute phase (2). 
Brucella species reproduce inside cells and 
escape from innate and acquired immune 
system. Also, the member of the genus 
Brucella can replicate within macrophages and 
cause infection and disease in animals and 
humans (3). Twelve nomen species: B.abortus, 
B.melitensis, B. suis, B.canis, B.ovis, 
B.neotomae, The first six bacteria are classical 
species (4). B. pinnipediae (5), B. ceti (6), 
were separated from aquatic mammals and 
have a marine origin. B. inopinata separated 
from people (6), B. microti isolated from 
common voles (7). As of late, the separation of 
B.papionis from baboons was depicted, and 
the last one, which isolated from mandibular 
lymph nodes of red foxes (Vulpes vulpes) was 
B. vulpis. The genus of Brucella has been a 
member of the alpha - 2 subdivision of the 
class proteobacteria, which is closely related to 
Rochalmia. Rhizobium and Agrobacterium 
spp. (8, 9). Usually, the detection of this 
zoonosis is based on microbiological and 
serological technique tests. Although the gold 
standard test is the isolation of causative 
agents and cultured in microbial media such as 
blood culture, this technique has been needed 
long incubation periods, however, the 
sensitivity of this technique is low, 15% to 
70% (10,11). The presence of antibodies in the 
serum does not mean an active case of 
brucellosis, patients from areas where 
brucellosis is endemic often show a low 
serological response, and animal vaccination 
may have been false-positive results and also 
cross- reaction may occur between other gram- 
negative bacteria and smooth Brucella spp. 
(12,13). 
For diagnosis of many infectious diseases 
caused by slower growth as fastidious bacteria 
amplification of DNA by PCR is used, 
especially for detecting Brucella DNA (14, 15, 
16). However, the molecular assay such as 
DNA – based technique has proved to be fast 
(<4h) (17).   
The present survey compares 3 PCR 
techniques for detecting Brucella DNA from 
human serum samples of suspected patients 
with brucellosis clinical symptoms and 
arbitrates the technique most suitable for use 
in a diagnostic microbiology laboratory in 
terms of sensitivity, robustness, and easy to 
apply. Three primers include B4/B5 primers, 
the designed primers of IS711 sequences, and 
16SrRNA primers. 
 
Materials and Methods 
Between October 2017 to July 2018, a transect 
study was conducted, based on serum and 
blood sampling of suspected patients from the 
different provinces in Iran together with an 
epidemiological survey. The patient samples 
were gathered for 10 months. Two patients 
from Babol, 2 from Shiraz, 6 patients from 
Mashhad, 4 from Borujerd, 4 from Urmia, 3 
from Makoo, 24 from Khoy, and 4 from 
Tabriz. The study was approved by the Faculty 
of Medicine, Tehran Islamic Azad University 
of Medical Sciences, Research Ethics 
Committee, with approval ID: IR. IUA. TMU. 
REC: 1397. 245. 
After informed consent, serum and blood 
specimens were gathered from 49 suspected 
cases of patients with brucellosis symptoms 
who were referred to hospital and diagnostic 
laboratories in different cities from northern 
(4.08%), southern (4.08%), western (79.59%) 
and eastern (12.24%) provinces in Iran, during 
10 months. On the same day, that blood 
samples were collected, serum samples were 
also prepared. Before blood collection, we 
prepared the questionnaire form for each of the 
patients which contain: individual information 
of patients such as age, genus, job, city, 
primary clinical symptoms, and end all was an 
ethical testimonial of each patient. 
The isolated serum sample of patients was 
kept in tubes containing sodium citrate. The 
DNA was extracted from the serum specimens 
of 200µL volume, according to the guideline 
commercial kit (GTP. Tehran, Iran). 
The three primer pairs that were chosen 
amplified regions of three different Brucella 
genes, which used after bioinformatics 
analysis:  
First, B4 (5´-TGG CTC GGT TGC CAA TAT 
CAA-3´) and B5 (5´-CGC GCT TGC CTT 
TCA GGT CTG-3´), with a target gene 
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a conserved sequence in all species of Brucella 
[21], which amplified 223 bp fragment. The 
reaction consisted of 12.5µL 2X PCR master 
mix (Ampliqon, Denmark), 5 µL DNA 
template, 0.5 µL of each primer, and nuclease-
free water up to 25 µL. The thermo-cycler 
(Touchgene Gradient PCR Machine) was 
programmed as follows: Initial denaturation at 
95°C for 5 min, 35 cycles of template 
denaturation at 94°C for 1 min, 30 S for primer 
annealing at 60°C and 60 S for primer 
extension at 72°C with final extension cycle at 
72°C for 7 min. 
Second, using primer pair derived from the 
16SrRNA sequence of Brucella melitensis 
Rev. 1.    F (5´- GAT GTG GTA ACG CAC 
ACC AA-3´) and R (5´- CGC AGA CAG 
TGA CCA TCA AA-3´) amplified a 218 bp 
fragment. The 16SrRNA PCR assay was 
carried out in a total volume of 25 µL 
containing the same mixture, which was used 
for PCR. The gene amplification using the 
16SrRNA primer was programmed as same as 
first one, but 60 S for primer annealing at 
59°C.  
Third, IS711 specific primer, which was 
designed, based on the sequence of 
B.melitensis deposited in the GenBank. The 
IS711 primer pairs were designed by using the 
Codoncode Aligner software (V.7.1.2). The 
designed primers, F (5´-CGC TCG CTG CCA 
TAC TTG CA-3´) and R (5´-CTG AAC AAG 
CCG GGC CTG AT-3´) amplified a 448 bp 
fragment, which was a reiterative genetic 
compenent of IS711 and was special to 
Brucella spp. At least, one copy of this 
repetitive genetic element may appear as a 
common locus in all species of Brucella (7). 
The IS711 PCR assay was carried out in a total 
volume of 25 µL containing the same mixture, 
which was used for PCR. The PCR machine 
program of IS711 primer pairs was as same as 
the others except the primer annealing at 63°C 
was the 60S.  
In each PCR test, a positive control extricated 
DNA from B.melitensis Rev. 1, and B. abortus 
S19, and negative control extricated DNA 
from E. coli (ATCC 35218) were utilized to 
control the running procedure and the 
nonappearance of cross-contamination. All the 
standard items were checked for the 
prevention of any probable contamination. The 
tests were carried out twice. After the 
amplification process, the samples were run on 
1.2% agarose gel (Sigma). The gel was stained 
by 1 µg/ml ethidium bromide and after 
distaining, the DNA bands were visualized 
within Gel documentation UV chamber. For 
some of the amplified products of BCSP31, 
IS711, and 16srRNA genes, DNA sequencing 
has been performed after that, DNA sequences 
were edited by Chromaspro Version 2.1.3 
(Technelysium Pty Ltd, Australia) and BioEdit 
Version 7.0.5.3.  Finally, a standard nucleotide 
blast has been done in NCBI. 
Sensitivity assay 
In the present study, for colony-forming unit 
(CFU) calculation, a 48h incubated suspension 
of B. melitensis and B. abortus within sterile 
PBS was utilized for preparing serial dilutions 
from 10-1 to 10-10. 0.1 ml from each dilution 
was cultured onto the Brucella agar medium 
and incubation process was as follows: 37°C 
for 72h. Then, the colonies of B. melitensis 
and             B. abortus were counted and the 
bacterial concentration was calculated to be 
about 5 x108 CFU/ml for both B. melitensis 
and B. abortus. At that point a serial dilution 
of extricated refined DNA of B. melitensis and 
B. abortus was prepared from 10-1 to 10-10. 
Afterward, five microliters of each dilution 
were utilized as template in the PCR process. 
No amplification was detected with the E. coli 
DNA template.  
For statistical analysis utilized the chi-square 
test. The P-value for all variables was less than 
0.01 (P < 0.01) so the differences were 




In this research, the geographical distribution 
of patient samples in different cities was 
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Amplification with BCSP31-PCR 
Detection of the Brucella genus with B4 and 
B5 primers is shown in figure 2. As expected, 
The BCSP31 gene amplicon size was 223 bp, 
and all the 49 (100%) serum specimens 
isolated from patients were positive by B4 and 
B5 primers. 
 
Amplification with 16SrRNA –PCR 
16SrRNA primers did detection of Brucella in 
serum samples. The positive result is shown in 
figure 3. The amplicon of 16SrRNA is made 
of 218 bp. Among the 49 serum samples 
isolated from patients, 15 (30.61%) cases were 
positive. 
 
Amplification with IS711–PCR 
Detection of Brucella in serum samples was 
performed by designed IS711 primers, which 
were specific to the Brucella genus. The 
positive result is shown in figure 4. The 
amplicon of IS711 is made of 448 bp. 46 
(93.87%) cases from 49 serum samples were 
positive. 
 
Testing of the sensitivity  
The sensitivities of three primer pairs (B4-B5 
and IS711 and 16SrRNA) were evaluated by 
using serial dilutions of extracted purified 
DNA molecules of B. melitensis and B. 
abortus. The comparative values of related 
primers are indicated in figures 5, 6, and 7.	
The designed IS711 primer pairs were able to 
distinguish bacterial cells with the sum of 2 
CFU/reaction for both B. melitensis and B. 
abortus, whereas the B4-B5 primers were able 
to identify bacterial cells with the sum of 0.05 
CFU/reaction for both them. And 16SrRNA 
primers could detect 2×105 CFU/reaction. 
Since it has been estimated that 20 Brucella 
cells are equal with 60 fg of bacterial DNAs 
(19), It is estimated that B4-B5 primers can 
detect 1.5 pg of DNA while the novel primers 
of IS711 can detect the amount of 0.15 ng of 
DNA and 16SrRNA are able to detect about 15 
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Discussion 
As the clinical symptoms of human brucellosis 
are not specific (20,21), it is necessary to use 
laboratory assays, which have high sensitivity 
and specificity to obtain true and sharp results 
in a short time. PCR is one of this techniques 
but PCR needs to be optimized (22, 23). Other 
techniques such as culture media and 
serological tests have low sensitivity and 
specificity (23, 24). PCR is a gold molecular 
technique for detecting fastidious bacteria such 
as Brucella (18). 
In this project, 49 serum samples from 
suspected patients were gathered from 
different cities of Iran. For detection of 
Brucella spp.	 To select the optimum pair of 
primers which would specifically amplify 
Brucella DNA, we have used to PCR assay 
with 3 primer pairs including B4/B5, IS711, 
16SrRNA, the sensitivity, and specificity of 
them were compared with each other. So, the 
sensitivity and specificity of three targets, 
BCSP 31 and designed IS711 genes and 
16SrRNA were compared by PCR. In other 
experiments, the properties of sensitivity and 
specificity of different PCR protocols in 
association with the target gene of BCSP31 for 
detection of Brucella DNA in human blood or 
serum samples varies between 50% and 100%, 
respectively (20,24,25,26). The specificity of 
the B4-B5 PCR assay, as well as the other 
primer pair assays, was excellent according to 
previous results (14, 20, 24, 27 and 28). In 
another survey by Queipo-Ortuno et al. in 
1997 used PCR with B4/B5 primers examined 
47 peripheral blood samples; the best 
sensitivity (100%) was reported in comparison 
with blood culture and serology (70% and 
84%, respectively). Our results indicate that: 
the sensitivity and specificity of B4/B5 
primers both of them were 100%. The PCR 
method with designed primers of IS711 
distinguished the huge number of Brucella 
spp. in serum samples. These primers could 
detect at least 0.2×101 CFU/ ml bacteria in the 
samples and be about 2.5×102 times more 
sensitive than the other IS711 primers, which 
were used in the detection of this gene by 
Ciftci in Turkey. They could detect 5×102 
CFU/ml bacteria by IS711 primers (23). These 
accomplishments affirm the PCR comes about 
that were detailed by Khosravi (29) and Elfaki 
(30). In these studies, a large number of B. 
melitensis DNA was identified by utilizing the 
IS711 primers. In any case, our discoveries are 
altogether diverse from the details that come 
about by Garshasbi. Within the performed 
think about by Garshasbi, the sensitivity is 
bellow and a huge number of B. abortus DNA 
was detectable by using the IS711 primers 
(31).  
In this study, the use of diluted Brucella DNA 
(1 to 10 in water) did not improve the overall 
sensitivity of the B4-B5 or IS711 primer pairs 
and was not accepted as a routine. Moreover, 
the detection of Brucella is limited to 0.05 
CFU/reaction by B4-B5 primers 
with100%sensitivity, while the detection is 
limited to 5 CFU/reaction by designed IS711 
primer with 93.87% sensitivity, the results 
suggest that the 3 samples with negative 
results are caused by the inadequate number of 
bacteria existing in the serum samples., and 
the detection is limited to 5×105 CFU/reaction 
by 16SrRNA primer with 30.61% sensitivity. 
The result of 16SrRNA primers, indicate at 
least sensitive and needed the highest number 
of the cells to give a positive bond; all 
attempts at improving its results were 
unsuccessful. It is beneficial to specify that 
diverse sums of template DNA were utilized 
extending from 1 to 5 µL to dispose of the 
conceivable response restraint of the template 
DNA inhibitors. This study aimed to develop a 
novel molecular method for the detection and 
identification of Brucella spp., which may be 
the gold standard demonstrative strategy for 
brucellosis both in creatures and people is still 
based on the separation of Brucella spp. inside 
the samples (28). 
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